Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:17 PM
Ignite Modification Date:
2025-12-24 @ 2:17 PM
NCT ID:
NCT06589895
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Patients with moderate to severe Crohn's disease
* Failure of at least one immunosuppressant and one anti-TNF alpha agent
* Patients on Risankizumab
* No opposition to study participation
Exclusion Criteria:
* Age \< 18 years
* UC
* Unclassified colitis
* Risankizumab prescribed to prevent post-operative relapse
* Any contraindication to Risankizumab
* Refusal to participate in study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06589895
Study Brief:
Protocol Section:
NCT06589895